GeneEdit vs Intellia Therapeutics

GeneEdit vs Intellia Therapeutics, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: GeneEdit is on 8/100 and Intellia Therapeutics on 40/100.

GeneEditDeveloping gene editing therapies for rare genetic diseases.
Try GeneEdit
Intellia Therapeutics logo
Intellia TherapeuticsA clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
Try Intellia Therapeutics

Where each one leads

GeneEdit

Leads on none of the measures we hold for both companies.

Intellia Therapeutics

  • our overall score: 40/100 against 8/100
  • agent readiness: 42/100 against 31/100

At a glance

MeasureGeneEditIntellia Therapeutics
What it isDeveloping gene editing therapies for rare genetic diseases.A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
CategoryBiotech, MedTech, HealthTech, GenomicsBiotech, MedTech, Genomics, Drug Discovery
Sells toBusiness modelB2BB2B
OfferingServicesPlatform
Founded20232014
HeadquartersNew York, United StatesCambridge, United States
StatusActiveActive

Size, funding and growth

MeasureGeneEditIntellia Therapeutics
Total fundingNot published$310M
Latest roundNot publishedSeries C
LinkedIn followersNot published71,640

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureGeneEditIntellia Therapeutics
StartupHub scoreOur 0-100 rating8/10040/100
TractionNot published40/100
Team10/10070/100
Search visibility2/10031/100
QualityNot published35/100
Agent readinessHow well an AI agent can read and act on the siteF (31/100)D (42/100)
Domain ratingLink authority, 0-100Not published60/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureGeneEditIntellia Therapeutics
CDNCloudflareCloudflare
CMSNot detectedWordPress
FrameworksBootstrapJquery
AnalyticsNot detectedGoogle Analytics 4, Hotjar, Fathom

GeneEdit vs Intellia Therapeutics: common questions

Which is better, GeneEdit or Intellia Therapeutics?

On our 0-100 score Intellia Therapeutics rates higher (40/100 against 8/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.

How do GeneEdit and Intellia Therapeutics compare on the numbers?

Intellia Therapeutics leads on our overall score (40/100 against 8/100), agent readiness (42/100 against 31/100).

Read the full GeneEdit review and pricing or the Intellia Therapeutics review and pricing. You can also browse other GeneEdit alternatives we track.